Product Code: 01-PCNV-26
From £489.00
Deadline to order: 28/02/2026
Postnatal Constitutional CNV Detection using array based, or NGS approaches (Germline DNA).
Genomic deletions and duplications
Array based, NGS, Whole genome analysis (CNV)
English
DNA (in TE Buffer)
Yes
May 2026
May - August 2026
December 2026 - January 2027
You can complete purchase on our secure partner site.
The scheme is designed to assess the analytical process (genotyping), and reporting (biological and clinical interpretation of the test result) including the overall report layout, content and clerical accuracy.
Two mock clinical cases with matching samples will be provided. Approximately 1µg DNA per sample is provided. Complete information will be available in the scheme instructions.
Participants will receive an individual report including educational advice and a scheme report which includes additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics allowing participants to benchmark their results.
Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.
Applicable to laboratories using either array or NGS based technologies to detect large scale genomic / structural changes and CNV. This EQA is platform independent.
Participants are expected to test samples according to their routine strategy and to return a clinical report.
No restrictions on number of participants. Open to laboratories from ALL countries (note: some restrictions may apply due to sanctions, delivery network exceptions, restrictions on importation etc).
This EQA scheme is run in collaboration with GenQA
added wishlist!
View Wishlist
View Wishlist
Express your interest in ''.
